These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1386485)

  • 41. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.
    Mengistu M; Ray K; Lewis GK; DeVico AL
    PLoS Pathog; 2015 Mar; 11(3):e1004772. PubMed ID: 25807494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.
    Stamatatos L; Lim M; Cheng-Mayer C
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):981-94. PubMed ID: 10890360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4.
    Hartley CA; Gilbert MJ; Brigido L; Elbeik T; Levy JA; Crowe SM; Mills J
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2015-23. PubMed ID: 8810998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies.
    Moore JP; Sattentau QJ; Clapham PR
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1273-9. PubMed ID: 2078408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.
    Maeda Y; Matsushita S; Hattori T; Murakami T; Takatsuki K
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2049-54. PubMed ID: 1493053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.
    Nichols CN; Bernal I; Prince AM; Andrus L
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):49-56. PubMed ID: 11804556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1.
    Bouma P; Leavitt M; Zhang PF; Sidorov IA; Dimitrov DS; Quinnan GV
    J Virol; 2003 Jul; 77(14):8061-71. PubMed ID: 12829845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
    Hwang SS; Boyle TJ; Lyerly HK; Cullen BR
    Science; 1992 Jul; 257(5069):535-7. PubMed ID: 1636088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.
    Sato H; Orenstein J; Dimitrov D; Martin M
    Virology; 1992 Feb; 186(2):712-24. PubMed ID: 1370739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study.
    Meerloo T; Sheikh MA; Bloem AC; de Ronde A; Schutten M; van Els CA; Roholl PJ; Joling P; Goudsmit J; Schuurman HJ
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():129-35. PubMed ID: 8093711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120.
    Gilbert M; Kirihara J; Mills J
    J Clin Microbiol; 1991 Jan; 29(1):142-7. PubMed ID: 1993748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.
    Blay WM; Kasprzyk T; Misher L; Richardson BA; Haigwood NL
    J Virol; 2007 Dec; 81(23):13037-49. PubMed ID: 17855534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding.
    Mariner JM; McMahon JB; O'Keefe BR; Nagashima K; Boyd MR
    Biochem Biophys Res Commun; 1998 Jul; 248(3):841-5. PubMed ID: 9704015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Covalently crosslinked complexes of human immunodeficiency virus type 1 (HIV-1) gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates.
    Devico A; Silver A; Thronton AM; Sarngadharan MG; Pal R
    Virology; 1996 Apr; 218(1):258-63. PubMed ID: 8615032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
    Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
    J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma.
    Igarashi T; Brown C; Azadegan A; Haigwood N; Dimitrov D; Martin MA; Shibata R
    Nat Med; 1999 Feb; 5(2):211-6. PubMed ID: 9930870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.